XML 96 R86.htm IDEA: XBRL DOCUMENT
v3.25.2

Transactions and Balances with Related Parties (Details) - USD ($) $ / shares in Units, $ in Thousands |  |  |  |  |  |  |  |  |  |  |  | 1 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Dec. 30, 2024 | Oct. 31, 2024 | Aug. 13, 2024 | Jan. 31, 2024 | Aug. 18, 2023 | Mar. 22, 2023 | Feb. 23, 2023 | Nov. 17, 2022 | Nov. 01, 2022 | Sep. 15, 2022 | Aug. 02, 2022 | Nov. 30, 2023 | Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022
Transactions and Balances with Related Parties [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate |  |  |  |  |  |  | 49.00% |  |  |  |  |  |  |  |
Cash consideration |  |  |  |  |  |  | $ 2,500 |  |  |  |  |  | $ 4,540 |  |
Deferred cash payments |  |  |  |  |  |  | $ 489 |  |  |  |  |  |  |  |
Share capital percentage |  |  |  | 51.00% |  |  |  | 9.33% |  |  |  |  |  |  |
Other fee expenses |  |  |  | $ 20 |  |  |  |  |  |  |  | $ 10 |  |  |
Bonus amount |  |  |  | $ 51 |  |  |  |  |  |  |  |  |  |  |
Services expenses |  |  |  |  |  |  |  |  |  |  |  |  | 105 |  |
Engaged in a mutual share exchange |  |  |  |  |  |  |  |  |  |  |  |  | $ 497 | $ 497 |
Acquired ordinary shares (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  | 35,345 |  |
Aggregate value |  |  |  |  |  |  |  |  |  |  |  |  | $ 288 |  |
Aggregate values adjusted |  |  |  |  |  |  |  |  |  |  |  |  | $ 300 |  |
Ownership percentage |  |  |  |  |  |  |  |  |  |  |  |  | 4.99% |  |
Listed share price (in Dollars per share) |  |  |  |  |  |  |  |  |  |  |  |  | $ 2.57 |  |
Cooperation Agreement amount |  |  |  |  |  |  |  |  |  |  |  |  | $ 63 | $ 40 |
Current investments |  |  |  |  |  |  |  | $ 1,500 |  |  |  |  |  |  |
Exchange of Common Shares (in Shares) |  |  |  |  |  |  |  | 7,692 |  |  |  |  |  |  |
Outstanding share capital, percentage |  |  |  |  |  |  |  | 9.33% |  |  |  |  |  |  |
Licensee issue price |  |  | $ 805 |  |  |  |  |  |  |  |  |  |  |  |
Milestones amount |  |  | $ 3,320 |  |  |  |  |  |  |  |  |  |  |  |
License agreement, description |  |  | (i) $50 upon a successful preclinical safety test, (ii) $100 upon first patient enrolled in phase I clinical trial, (iii) $120 upon first patient enrolled in Phase 2a clinical trial, (iv) $150 upon first patient enrolled in Phase 2b clinical trial, (v) $500 upon first patient enrolled in Phase 3 clinical trials, (vi) $800 upon approval by the U.S. Food and Drug Administration, (vii) $800 upon approval by an EU regulatory body, and (viii) $800 upon regulatory approval in any additional jurisdiction. |  |  |  |  |  |  |  |  |  |  |  |
Aggregate net sales |  |  | 5.00% |  |  |  |  |  |  |  |  |  |  |  |
Units received (in Shares) |  |  |  |  | 75,000,000 | 660 |  |  | 68 | 75,000,000 | 44 |  | 30,770 |  |
Number of shares issued (in Shares) | 1,541,096 |  |  |  |  |  |  |  |  |  |  |  | 515,631 | 33,652 |
Aggregate consideration | $ 771 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate number of the outstanding ordinary shares |  |  |  |  |  |  |  |  |  |  |  |  | 50.01% |  |
Jeffs’ Brands [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Transactions and Balances with Related Parties [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Services expenses |  |  |  |  |  |  |  |  |  |  |  |  | $ 120 | $ 220 |
Engaged in a mutual share exchange |  |  |  |  |  |  |  |  |  |  |  |  | $ 288 |  |
Acquired ordinary shares (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  | 660 |  |
Loss on investment |  |  |  |  |  |  |  |  |  |  |  |  | $ 17 | $ 180 |
Merger Agreement [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Transactions and Balances with Related Parties [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate number of the outstanding ordinary shares |  |  |  |  |  |  |  |  |  |  |  |  | 49.99% |  |
Initial Public Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Transactions and Balances with Related Parties [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of units (in Shares) |  | 684,931 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Transactions and Balances with Related Parties [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase price per share (in Dollars per share) |  | $ 4.38 |  |  |  |  |  |  |  |  |  |  | $ 4.38 |  |
Units received (in Shares) |  | 2,054,793 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants holds (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  | 513,698 |  |
Warrants expire date |  |  |  |  |  |  |  |  |  |  |  |  | Oct. 31, 2029 |  |
Warrants fair value |  | $ 1,399 |  |  |  |  |  |  |  |  |  |  | $ 517 |  |
Pre-Funded Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Transactions and Balances with Related Parties [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of units (in Shares) |  | 364,931 |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase price per share (in Dollars per share) |  | $ 4.38 |  |  |  |  |  |  |  |  |  |  |  |  |
Units received (in Shares) |  | 1,094,793 |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued (in Shares) |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,881
Ordinary Share [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Transactions and Balances with Related Parties [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of units (in Shares) |  | 320,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase price per share (in Dollars per share) |  | $ 4.38 |  |  |  |  |  |  |  |  |  |  |  |  |
Units received (in Shares) |  | 320,000 |  |  |  |  |  |  |  |  |  |  | 30,770 |  |
Ordinary Share [Member] | Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Transactions and Balances with Related Parties [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Units received (in Shares) |  | 960,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Ordinary Share [Member] | Pre-Funded Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Transactions and Balances with Related Parties [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Units received (in Shares) |  | 364,931 |  |  |  |  |  |  |  |  |  |  |  |  |

X
- Definition The amount of cash on hand and demand deposits. [Refer: Cash on hand] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 7 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_Cash
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Total for all subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2024-01-01 -Paragraph 40 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_40_a&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ConsiderationPaidReceived
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of current investments. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_55&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_CurrentInvestments
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The increase (decrease) in the number of ordinary shares issued. [Refer: Ordinary shares [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 112 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_112_c&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_IncreaseDecreaseInNumberOfOrdinarySharesIssued
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of shares issued by the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 106 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfSharesIssued
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of fee and commission expense that the entity does not separately disclose in the same statement or note. [Refer: Fee and commission expense] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 112 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_112_c&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_OtherFeeAndCommissionExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2024-01-01 -Paragraph 17 -Subparagraph b -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_17_b_iii&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2024-01-01 -Paragraph 16 -Subparagraph b -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2024-en-r&anchor=para_16_b_iii&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2024-01-01 -Paragraph 19B -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_19B_c&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ProportionOfOwnershipInterestInSubsidiary
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 21 -IssueDate 2024-01-01 -Paragraph 52 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2024-en-r&anchor=para_52_b&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ReserveOfExchangeDifferencesOnTranslation
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of expense arising from services. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 85 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_85&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ServicesExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The weighted average fair value at the measurement date of granted equity instruments other than share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_b&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The number of shares acquired. + References No definition available. + Details
Name: | sprcy_AcquiredOrdinaryShares
Namespace Prefix: | sprcy_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Aggregate number of the outstanding ordinary shares. + References No definition available. + Details
Name: | sprcy_AggregateNumberOfOutstandingOrdinarySharesPercentage
Namespace Prefix: | sprcy_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of aggregate values adjusted. + References No definition available. + Details
Name: | sprcy_AggregateValueAdjusted
Namespace Prefix: | sprcy_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of aggregate value. + References No definition available. + Details
Name: | sprcy_AggregateValues
Namespace Prefix: | sprcy_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Bonus amount received. + References No definition available. + Details
Name: | sprcy_BonusAmountReceived
Namespace Prefix: | sprcy_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of comprehensive loss on investment. + References No definition available. + Details
Name: | sprcy_ComprehensiveLossOnInvestment
Namespace Prefix: | sprcy_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Cooperation Agreement amount. + References No definition available. + Details
Name: | sprcy_CooperationAgreementAmount
Namespace Prefix: | sprcy_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Deferred cash payments amount. + References No definition available. + Details
Name: | sprcy_DeferredCashPayment
Namespace Prefix: | sprcy_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of shares exchanged. + References No definition available. + Details
Name: | sprcy_ExchangeOfCommonShares
Namespace Prefix: | sprcy_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Interest percentage. + References No definition available. + Details
Name: | sprcy_InterestPercentage
Namespace Prefix: | sprcy_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The description of the license agreement. + References No definition available. + Details
Name: | sprcy_LicenseAgreementDescription
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of licensee, reflecting an issue. + References No definition available. + Details
Name: | sprcy_LicenseeIssuePrice
Namespace Prefix: | sprcy_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of listed shares price per share. + References No definition available. + Details
Name: | sprcy_ListedSharePrice
Namespace Prefix: | sprcy_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Milestones amount. + References No definition available. + Details
Name: | sprcy_MilestonesAmount
Namespace Prefix: | sprcy_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of units received. + References No definition available. + Details
Name: | sprcy_NumberOfUnitsReceived
Namespace Prefix: | sprcy_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of warrants holds. + References No definition available. + Details
Name: | sprcy_NumberOfWarrantsHolds
Namespace Prefix: | sprcy_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of outstanding share capital. + References No definition available. + Details
Name: | sprcy_OutstandingShareCapital
Namespace Prefix: | sprcy_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of aggregate net sales. + References No definition available. + Details
Name: | sprcy_PercentageOfAggregateNetSales
Namespace Prefix: | sprcy_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The purchase price is the price an investor pays for an investment, and the price becomes the investor's cost basis for calculating gain or loss when selling the investment. + References No definition available. + Details
Name: | sprcy_PurchasePricePerShare
Namespace Prefix: | sprcy_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Share capital percentage. + References No definition available. + Details
Name: | sprcy_ShareCapitalPercentage
Namespace Prefix: | sprcy_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants expire date. + References No definition available. + Details
Name: | sprcy_WarrantsExpireDate
Namespace Prefix: | sprcy_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=sprcy_JeffsBrandsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=sprcy_MergerAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_SaleOfStockAxis=sprcy_InitialPublicOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfAntidilutiveInstrumentsAxis=sprcy_PrefundedWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |